F-group (family)
210.2.1.1 PP2C
Ligands and drugs
812
Member domains
109
with ligand contacts (≤ 4 Å)
13.4% of members
94
with DrugDomain annotations
11.6% of members
49
with a DrugBank compound
6.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 210.2.1.1 belongs to X-group 210 Ntn/PP2C, which binds 7.8 ligand superclasses per 20 proteins, broader than 53% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB16829 | A8S | Abscisic Acid | 17 |
| DB03345 | BME | Mercaptoethanol | 2 |
| DB00161 | VAL | Valine | 1 |
| DB06757 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 53 |
| MNmetal | MANGANESE (II) ION | 39 |
| CL | CHLORIDE ION | 15 |
| CAmetal | CALCIUM ION | 6 |
| NImetal | NICKEL (II) ION | 4 |
| ZNmetal | ZINC ION | 3 |
| 3UZ | (2S)-2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)ethanamide | 2 |
| BME | BETA-MERCAPTOETHANOL | 2 |
| PRmetal | PRASEODYMIUM ION | 2 |
| A1O | Quinabactin | 1 |
| NAmetal | SODIUM ION | 1 |
| WI5 | {(3R)-5-methyl-3-[(morpholin-4-yl)methyl]-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl}(naphthalen-1-yl)methanone | 1 |